Company Profiles

driven by the PitchBook Platform

RhinoCyte

RhinoCyte
2005 FOUNDED
OOB STATUS
Out of Business LATEST DEAL TYPE
$11.7M TOTAL AMOUNT RAISED
Description

Developer of a regenerative therapy designed to treat degenerative and traumatic neurological diseases. The company's regenerative therapy repairs life-altering or even life-threatening damage resulting from spinal cord injury and neurological disorders such as Parkinson's disease, amyotrophic lateral sclerosis (ALS), multiple sclerosis and Type 1 diabetes, using stem cells, enabling patients suffering from a neurological disorder to get proper treatment.

Ownership Status
Out of Business
Financing Status
Formerly VC-Backed
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Primary Office
1044 East Chestnut Street
Louisville, KY 40204
United States

+1 (502) 410-4512
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore RhinoCyte’s full profile, request a free trial.

RhinoCyte Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Out of Business 01-Jul-2016 $11.7M Completed Out of Business
7. Later Stage VC 07-Oct-2015 00000 000.00 Completed Generating Revenue
6. Later Stage VC (Series A1) 08-Jul-2014 00000 000.00 Completed Generating Revenue
5. Convertible Debt 22-Oct-2012 00000 000.00 Completed Generating Revenue
4. Later Stage VC 18-Nov-2011 00.000 000.00 Completed Generating Revenue
3. Early Stage VC 14-Oct-2009 00.000 00.000 Completed Startup
2. Convertible Debt 04-Sep-2008 $467k $1.4M Completed Startup
1. Early Stage VC (Series A) 23-Jun-2006 $930k $930k $1.68M Completed Startup
To view this company’s complete deal history including valuation and funding request access »

RhinoCyte Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table request access »

RhinoCyte Executive Team (2)

Name Title Board
Seat
Contact
Info
Fred Roisen Ph.D Co-Founder, Board Member & Chief Scientific Officer
Steve Gailar Co-Founder, Board Member & Advisor

RhinoCyte Board Members (4)

Name Representing Role Since Contact
Info
Michael Curtin Self Board Member 000 0000

3 Former Board Members

You’re viewing 1 of 4 board members. Get the full list »